Literature DB >> 18337244

Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH: role of penicillin-binding protein PBP 2a.

Sandrine Lemaire1, Cosimo Fuda, Françoise Van Bambeke, Paul M Tulkens, Shahriar Mobashery.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a global scourge, and treatment options are becoming limited. The MRSA phenotype reverts to that of beta-lactam-sensitive S. aureus when bacteria are grown at pH 5.0 in broth and, more importantly from a medical perspective (protracted, relapsing infections), after phagocytosis by macrophages, where the bacteria thrive in the acidic environment of phagolysosomes. The central factor for the MRSA phenotype is the function of the penicillin-binding protein (PBP) 2a, which maintains transpeptidase activity while being poorly inhibited by beta-lactams because of a closed conformation of its active site. We document herein by binding, acylation/deacylation kinetics, and circular dichroism spectroscopy with purified PBP 2a that at acidic pH (i) beta-lactams interact with PBP 2a more avidly; (ii) the non-covalent pre-acylation complex exhibits a lower dissociation constant and an increased rate of acyl-enzyme formation (first-order rate constant) without change in hydrolytic deacylation rate; and (iii) PBP 2a undergoes a conformational change in the presence of the antibiotic consistent with the opening of the active site from the closed conformation. These observations argue that PBP 2a most likely evolved for its physiological function at pH 7 or higher by adopting a closed conformation, which is not maintained at acidic pH. Although at the organism level the effect of acidic pH on other biological processes in MRSA could not be discounted, our report should provide the impetus for closer examination of the properties of PBP 2a at low pH and thereby identifying novel points of intervention in combating this problematic organism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337244      PMCID: PMC2442357          DOI: 10.1074/jbc.M800079200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Is Staphylococcus aureus an intracellular pathogen?

Authors:  F D Lowy
Journal:  Trends Microbiol       Date:  2000-08       Impact factor: 17.079

Review 2.  Emerging cephalosporins.

Authors:  Malcolm G P Page
Journal:  Expert Opin Emerg Drugs       Date:  2007-11       Impact factor: 4.191

Review 3.  Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting.

Authors:  Thomas M File
Journal:  Cleve Clin J Med       Date:  2007-08       Impact factor: 2.321

4.  Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus.

Authors:  M G Pinho; S R Filipe; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

5.  Fluorescent Bocillins: synthesis and application in the detection of penicillin-binding proteins.

Authors:  K R Gee; H C Kang; T I Meier; G Zhao; L C Blaszcak
Journal:  Electrophoresis       Date:  2001-03       Impact factor: 3.535

6.  Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study.

Authors:  M W H Wulf; M Sørum; A van Nes; R Skov; W J G Melchers; C H W Klaassen; A Voss
Journal:  Clin Microbiol Infect       Date:  2007-11-06       Impact factor: 8.067

7.  Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.

Authors:  Todd A Davies; Malcolm G P Page; Wenchi Shang; Ted Andrew; Malgosia Kania; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

Review 8.  Mechanisms of antibiotic resistance in Staphylococcus aureus.

Authors:  Annalisa Pantosti; Andrea Sanchini; Monica Monaco
Journal:  Future Microbiol       Date:  2007-06       Impact factor: 3.165

9.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

10.  Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus.

Authors:  Deverick J Anderson; Daniel J Sexton; Zeina A Kanafani; Grace Auten; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2007-07-12       Impact factor: 3.254

View more
  19 in total

1.  A PBP 2 mutant devoid of the transpeptidase domain abolishes spermine-β-lactam synergy in Staphylococcus aureus Mu50.

Authors:  Xiangyu Yao; Chung-Dar Lu
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  A computational evaluation of the mechanism of penicillin-binding protein-catalyzed cross-linking of the bacterial cell wall.

Authors:  Qicun Shi; Samy O Meroueh; Jed F Fisher; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2011-03-18       Impact factor: 15.419

Review 3.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus.

Authors:  Jeshina Janardhanan; Renee Bouley; Siseth Martínez-Caballero; Zhihong Peng; Mayte Batuecas-Mordillo; Jayda E Meisel; Derong Ding; Valerie A Schroeder; William R Wolter; Kiran V Mahasenan; Juan A Hermoso; Shahriar Mobashery; Mayland Chang
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 5.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

Review 6.  The future of the β-lactams.

Authors:  Leticia I Llarrull; Sebastian A Testero; Jed F Fisher; Shahriar Mobashery
Journal:  Curr Opin Microbiol       Date:  2010-09-29       Impact factor: 7.934

7.  Antimicrobial activity against intraosteoblastic Staphylococcus aureus.

Authors:  Florent Valour; Sophie Trouillet-Assant; Natacha Riffard; Jason Tasse; Sacha Flammier; Jean-Philippe Rasigade; Christian Chidiac; François Vandenesch; Tristan Ferry; Frédéric Laurent
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

8.  Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  Sandrine Lemaire; Youri Glupczynski; Valérie Duval; Bernard Joris; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

9.  Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA.

Authors:  Jingru Meng; Hui Wang; Zheng Hou; Tao Chen; Jingguo Fu; Xue Ma; Gonghao He; Xiaoyan Xue; Min Jia; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

10.  Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.

Authors:  Sandrine Lemaire; Aurélie Olivier; Françoise Van Bambeke; Paul M Tulkens; Peter C Appelbaum; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.